DNER and nasopharyngeal carcinoma: In addition, DNER acts as a ligand for Notch1, activating the Notch signalling pathway11,15, and the knockdown of Notch1 expression can inhibit the migration and invasion of nasopharyngeal carcinoma cells by reversing EMT32.